M. Lazzaroni

2.2k total citations
78 papers, 1.5k citations indexed

About

M. Lazzaroni is a scholar working on Surgery, Gastroenterology and Pharmacology. According to data from OpenAlex, M. Lazzaroni has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 38 papers in Gastroenterology and 16 papers in Pharmacology. Recurrent topics in M. Lazzaroni's work include Helicobacter pylori-related gastroenterology studies (50 papers), Gastroesophageal reflux and treatments (25 papers) and Gastrointestinal motility and disorders (14 papers). M. Lazzaroni is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (50 papers), Gastroesophageal reflux and treatments (25 papers) and Gastrointestinal motility and disorders (14 papers). M. Lazzaroni collaborates with scholars based in Italy, United Kingdom and Sweden. M. Lazzaroni's co-authors include G. Bianchi Porro, G. Bianchi Porro, F. Parente, O. Sangaletti, Gabriele Bianchi Porro, Marco Petrillo, Gabriele Bianchi-Porro, M. J. Daly, S. Bargiggia and J. Næsdal and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

M. Lazzaroni

77 papers receiving 1.4k citations

Peers

M. Lazzaroni
Stanley M. Chernish United States
Mark Sostek United States
A J Swannell United Kingdom
Thomas Simon United States
Ali S. Taha United Kingdom
Naurang M. Agrawal United States
R P Walt United Kingdom
N Hudson United Kingdom
J. A. H. Forrest United Kingdom
Stanley M. Chernish United States
M. Lazzaroni
Citations per year, relative to M. Lazzaroni M. Lazzaroni (= 1×) peers Stanley M. Chernish

Countries citing papers authored by M. Lazzaroni

Since Specialization
Citations

This map shows the geographic impact of M. Lazzaroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lazzaroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lazzaroni more than expected).

Fields of papers citing papers by M. Lazzaroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lazzaroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lazzaroni. The network helps show where M. Lazzaroni may publish in the future.

Co-authorship network of co-authors of M. Lazzaroni

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lazzaroni. A scholar is included among the top collaborators of M. Lazzaroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lazzaroni. M. Lazzaroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foschi, Diego, M. Lazzaroni, O. Sangaletti, et al.. (2008). Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients. Digestive and Liver Disease. 40(8). 667–672. 28 indexed citations
2.
Cassinotti, A., Sarah Birindelli, Mario Clerici, et al.. (2008). HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists. The American Journal of Gastroenterology. 104(1). 195–217. 40 indexed citations
3.
Foschi, Diego, Fabio Corsi, M. Lazzaroni, et al.. (2006). Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. International Journal of Obesity. 31(4). 707–712. 57 indexed citations
4.
Lazzaroni, M. & G. Bianchi Porro. (2005). Preparation, Premedication, and Surveillance. Endoscopy. 37(2). 101–109. 104 indexed citations
5.
Lazzaroni, M. & G. Bianchi Porro. (2001). Helicobacter pylori and NSAID gastropathy. Alimentary Pharmacology & Therapeutics. 15(s1). 22–27. 6 indexed citations
6.
Lazzaroni, M. & Gabriele Bianchi-Porro. (1999). Premedication, Preparation, and Surveillance. Endoscopy. 31(1). 2–8. 36 indexed citations
7.
Lazzaroni, M., et al.. (1996). Eradication ofHelicobacter pylori and long-term outcome of functional dyspepsia. Digestive Diseases and Sciences. 41(8). 1589–1594. 30 indexed citations
8.
Porro, G. Bianchi, Roberto Corinaldesi, M. Lazzaroni, et al.. (1994). Long term treatment with omeprazole 20 mg three days a week or 10 mg daily in the prevention of duodenal ulcer relapse. Alimentary Pharmacology & Therapeutics. 8(5). 541–548. 7 indexed citations
9.
D’Adda, Tiziana, Francesco Paolo Pilato, M. Lazzaroni, et al.. (1991). Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. Gastroenterology. 100(6). 1563–1570. 11 indexed citations
10.
Bardhan, Karna Dev, J. Næsdal, G. Bianchi Porro, et al.. (1991). Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.. Gut. 32(4). 435–438. 32 indexed citations
11.
Porro, G. Bianchi, M. Lazzaroni, F. Parente, et al.. (1991). Diazemuls Versus Diazepam as Premedication in Upper Gastrointestinal Endoscopy: A Randomised Cross-Over Study. Endoscopy. 23(4). 203–205. 2 indexed citations
12.
Sabbatini, F, M. Lazzaroni, Marco Petrillo, et al.. (1990). Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer. European Journal of Clinical Pharmacology. 39(5). 515–7. 3 indexed citations
13.
Lazzaroni, M., Marco Petrillo, & G. Bianchi Porro. (1989). Comparison of qid and bd administration of De‐Nol in the short term treatment of duodenal ulcer. International Journal of Clinical Practice. 43(4). 151–155. 3 indexed citations
14.
Porro, G. Bianchi, M. Lazzaroni, Barbara Leggett, et al.. (1988). Tripotassium Dicitrate Bismuthate and Ranitidine in Duodenal Ulcer: Healing and Influence on Recurrence. Scandinavian Journal of Gastroenterology. 23(10). 1232–1236. 6 indexed citations
15.
Porro, G. Bianchi, Bruno P. Imbimbo, & M. Lazzaroni. (1988). Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients. Inflammation Research. 25(1-2). 22–26. 4 indexed citations
16.
Lazzaroni, M., Bruno P. Imbimbo, O. Sangaletti, & G. Bianchi Porro. (1988). Gastric Acid and Pepsin Secretion after Single Oral Doses of Mifentidine in Healthy Subjects. Scandinavian Journal of Gastroenterology. 23(7). 788–792. 2 indexed citations
17.
Porro, G. Bianchi, F. Parente, & M. Lazzaroni. (1987). Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.. Gut. 28(7). 907–911. 24 indexed citations
18.
Porro, G. Bianchi, et al.. (1987). Maintenance Therapy with Colloidal Bismuth Subcitrate in Duodenal Ulcer Disease. Digestion. 37(2). 47–52. 11 indexed citations
19.
Porro, G. Bianchi, et al.. (1987). Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients. European Journal of Clinical Pharmacology. 32(6). 555–558. 8 indexed citations
20.
Parente, F., M. Lazzaroni, O. Sangaletti, Stefano Baroni, & G. Bianchi Porro. (1985). Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients.. Gut. 26(12). 1327–1332. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026